ArticleFrontiers in pediatrics2026
Superselective bronchial artery embolization guided by bronchial artery CT angiography for pediatric hemoptysis and pulmonary hemorrhage: a retrospective single-center study.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Bronchial artery embolization (BAE) is an established first-line treatment for life-threatening hemoptysis in adults; however, evidence regarding its safety and efficacy in pediatric patients remains limited, particularly in children with idiopathic pulmonary hemosiderosis-associated pulmonary hemorrhage. Methods: This retrospective study evaluated the clinical efficacy, angiographic characteristics, and mid-term outcomes of bronchial artery (BA) computed tomography angiography-guided superselective BAE in 33 pediatric patients with hemoptysis or pulmonary hemorrhage treated between January 2018 and September 2025. All patients underwent preprocedural BA computed tomography angiography followed by digital subtraction angiography-guided embolization. Clinical characteristics, BA features, bleeding severity, procedural outcomes, and follow-up data were analyzed. Results: A total of 81 bronchial arteries were embolized, with a technical success rate of 100%, and no major procedure-related complications occurred. Bleeding severity was significantly associated with etiology ( Discussion: These findings suggest that BA computed tomography angiography-guided superselective BAE is a feasible and potentially beneficial minimally invasive treatment for pediatric hemoptysis and pulmonary hemorrhage and may be particularly valuable in children with idiopathic pulmonary hemosiderosis-associated life-threatening pulmonary hemorrhage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.